Innovation Days
About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2022
2021
2020
2019
2018
2017
16
May
2022
08:30 E.S.T.
Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT
Read more
12
May
2022
16:30 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022
Read more
05
May
2022
16:30 E.S.T.
Cellectis to Report First Quarter 2022 Financial Results
Read more
05
May
2022
16:00 E.S.T.
Calyxt, Inc., Cellectis’ Majority-Owned Subsidiary, Reports Its First Quarter 2022 Financial Results
Read more
28
Apr
2022
08:00 E.S.T.
Cellectis Publishes Two Articles in Nature Communications Providing Strong Preclinical Validation of UCART123 to Treat AML and BPDCN
Read more
27
Apr
2022
04:00 E.S.T.
Cellectis Receives $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
Read more
08
Apr
2022
16:30 E.S.T.
Cellectis Presents Preclinical Data from its First Allogeneic Dual CAR T-cell Product Candidate UCART20x22 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma at the American Association for Cancer Research (AACR) 2022 Annual Meeting
Read more
11
Mar
2022
13:15 E.S.T.
Cellectis to Participate in Two Upcoming Investor Conferences in March
Read more
03
Mar
2022
13:46 E.S.T.
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2021 Financial Results
Read more
24
Feb
2022
13:13 E.S.T.
Cellectis to Hold Fourth Quarter 2021 Earnings Call on Friday March 4, 2022 at 8:00AM EST
Read more
1
2
Next